InvestorsHub Logo
Followers 20
Posts 1676
Boards Moderated 0
Alias Born 07/09/2005

Re: None

Monday, 02/04/2019 5:32:27 PM

Monday, February 04, 2019 5:32:27 PM

Post# of 796
Duvelisib Effective After Progression on Ofatumumab in CLL
https://www.targetedonc.com/news/duvelisib-effective-after-progression-on-ofatumumab-in-cll
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent VSTM News